Table 4.

Complications and treatment of the 74 COVID-19 patients.

	Number of people (percentage)			P
	Total (n = 74)	ICU patient(n = 18)	Non-ICU patient(n = 56)
Complications
Shock	1 (1.35)	1 (5.56)	0 (0.00)	.243
Myocardial injury	3 (4.05)	2 (11.11)	1 (1.79)	.145
Arrhythmia	1 (1.35)	1 (5.56)	0 (0.00)	.243
Liver damage	5 (6.76)	3 (16.67)	2 (3.57)	.089
Renal impairment	3 (4.05)	2 (11.11)	1 (1.79)	.145
Acute respiratory distress syndrome	4 (5.41)	4 (22.22)	0 (0.00)	.03
Treatment
Antiviral	73 (97)	18 (100.00)	55 (98)	1
Antibiotic	60 (81.08)	18 (100.00)	42 (75.00)	.018
Glucocorticoid	4 (5.41)	2 (11.11)	2 (3.57)	.247
Interferon	16 (21.62)	12 (66.67)	4 (7.14)	<.001
Gamma globulin	15 (20.27)	11 (61.11)	4 (7.14)	<.001
Tocilizumab	4 (5.41)	4 (22.22)	0 (0.00)	1
Oxygen
High-flow	15 (20.27)	15 (83.33)	0 (0.00)	<.001
Nasal cannula	38 (51.35)	3 (16.67)	35 (62.50)	.001
Invasive ventilation	0 (0.00)	0 (0.00)	0 (0.00)	–
Number of viral nucleic acid testing until getting 2 consecutive negative results	4 (3–5)	4 (3–5)	4 (3–5)	.99
Deaths	1 (1.35)	1 (5.56)	0 (0.00)	.243